Three-time Grand Slam doubles champion Gabriela Dabrowski shared her breast cancer diagnosis on social media, disclosing that ...

Three-time Grand Slam doubles champion Gabriela Dabrowski shared her breast cancer diagnosis on social media, disclosing that she played through treatment when she won a bronze medal at the Paris ...

Gain Therapeutics' GT-02287 shows promise in treating Parkinson's disease, with positive results and potential for market ...

After reinvigorating a decades-old schizophrenia drug in an innovative long-acting treatment option, Teva is looking to ...

The prospect of increased federal involvement in assisted living bookended the year for senior living providers.

The medically-retired CIA officer spoke with investigative journalist Catherine Herridge about her experience with the ...

The University of California San Francisco (UCSF) is seeking participants for four clinical trials exploring the effects of ...

Brilaroxazine hydrochloride is under clinical development by Reviva Pharmaceuticals and currently in Phase I for Major Depressive Disorder.

Semorinemab (RG-6100) was under development for the treatment of mild to moderate Alzheimer’s disease. The drug candidate is administered through intravenous route which acts by targeting tau protein.

Core offers FDA-approved nVNS devices with growth potential in healthcare and military markets. Click here to find out what ...

A POPULAR nasal spray used to tackle a blocked nose may trigger Parkinson’s disease-like symptoms, a doctor has warned. Pseudoephedrine, a medicine found in many cold and flu medicines like ...

Difficulty swallowing or coughing while eating every so often isn't a big deal. However, there's a fine line between that and a more serious issue.